2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin

References

• Vishwakarma N, Jain A, Sharma R, et al. Lipid-based nanocarriers for lymphatic transportation. AAPS Pharm Sci Tech. 2019;20(2):83. doi:10.1208/s12249-019-1293-3
   PubMed Web of Science ®Google Scholar
• Qi J, Zhuang J, Lv Y, Lu Y, Wu W. Exploiting or overcoming the dome trap for enhanced oral immunization and drug delivery. J Control Release. 2018;275:92–106. doi:10.1016/j.jconrel.2018.02.021
   PubMed Web of Science ®Google Scholar
• Cheng H, Cui Z, Guo S, et al. Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin. Acta Biomater. 2021;135:506–519. doi:10.1016/j.actbio.2021.08.046
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lu Y, Qi J, Wu W. An update on oral drug delivery via intestinal lymphatic transport. Acta pharmaceutica Sinica B. 2021;11(8):2449–2468. doi:10.1016/j.apsb.2020.12.022
   PubMed Web of Science ®Google Scholar
• Alderfer L, Hall E, Hanjaya-Putra D. Harnessing biomaterials for lymphatic system modulation. Acta Biomater. 2021;133:34–45. doi:10.1016/j.actbio.2021.06.006
   PubMed Web of Science ®Google Scholar
• Xia F, Fan W, Jiang S, et al. Size-dependent translocation of nanoemulsions via oral delivery. ACS Appl Mater Interfaces. 2017;9(26):21660–21672. doi:10.1021/acsami.7b04916
   PubMed Web of Science ®Google Scholar
• Yang X, Ma C, Chen Z, et al. Single small molecule-assembled nanoparticles mediate efficient oral drug delivery. Nano Res. 2019;12(10):2468–2476. doi:10.1007/s12274-019-2470-0
   PubMed Web of Science ®Google Scholar
• Wong KH, Yang D, Chen S, He C, Chen M. Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: a review. Asian J Pharm Sci. 2022;17(4):475–490. doi:10.1016/j.ajps.2022.04.005
   PubMed Web of Science ®Google Scholar
• Chen Y, Tao T, Wang W, Yang B, Cha X. Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg/Th17 balance. Clin Exp Pharmacol Physiol. 2021;48(4):626–633. doi:10.1111/1440-1681.13461
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang Y, Jiang N, et al. Dihydroartemisinin regulates the immune system by promotion of CD8(+) T lymphocytes and suppression of B cell responses. Sci China Life Sci. 2020;63(5):737–749. doi:10.1007/s11427-019-9550-4
   PubMed Web of Science ®Google Scholar
• Diao L, Tao J, Wang Y, Hu Y, He W. Co-delivery of dihydroartemisinin and HMGB1 siRNA By TAT-modified cationic liposomes through The TLR4 signaling pathway for treatment of lupus nephritis. Int J Nanomed. 2019;14:8627–8645. doi:10.2147/ijn.S220754
   PubMed Web of Science ®Google Scholar
• Bai B, Wu F, Ying K, et al. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer. Theranostics. 2021;11(13):6225–6239. doi:10.7150/thno.55939
   PubMed Web of Science ®Google Scholar
• Li Y, Pei Q, Cui B, et al. A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity. J Nanobiotechnology. 2021;19(1):441. doi:10.1186/s12951-021-01200-z
   PubMed Web of Science ®Google Scholar
• Xu Y, Xiao L, Chen J, et al. α-Fe(2)O(3) based nanotherapeutics for near-infrared/dihydroartemisinin dual-augmented chemodynamic antibacterial therapy. Acta Biomater. 2022;150:367–379. doi:10.1016/j.actbio.2022.07.047
   PubMed Web of Science ®Google Scholar
• Liu G, Liu M, Li X, et al. Peroxide-simulating and GSH-depleting nanozyme for enhanced chemodynamic/photodynamic therapy via induction of multisource ROS. ACS Appl Mater Interfaces. 2023;15(41):47955–47968. doi:10.1021/acsami.3c09873
   PubMed Web of Science ®Google Scholar
• Su G, Xu H, Zhou F, et al. Boosting reactive oxygen species generation with a dual-catalytic nanomedicine for enhanced tumor nanocatalytic therapy. ACS Appl Mater Interfaces. 2023;15(51):59175–59188. doi:10.1021/acsami.3c13882
   PubMed Web of Science ®Google Scholar
• Dai X, Zhang X, Chen W, et al. Dihydroartemisinin: a potential natural anticancer drug. Int J Biol Sci. 2021;17(2):603–622. doi:10.7150/ijbs.50364
   PubMed Web of Science ®Google Scholar
• Chai L, Wang R, Wang Y, et al. Auto-induction of intestinal first-pass effect related time-dependent pharmacokinetics of artemisinin rather than dihydroartemisinin. J Pharm Sci. 2021;110(1):458–466. doi:10.1016/j.xphs.2020.09.023
   PubMed Web of Science ®Google Scholar
• Yan Y, Yang X, Han N, et al. Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production. J Nanobiotechnology. 2023;21(1):204. doi:10.1186/s12951-023-01959-3
   PubMed Web of Science ®Google Scholar
• Managuli RS, Raut SY, Reddy MS, Mutalik S. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs. Expert Opin Drug Deliv. 2018;15(8):787–804. doi:10.1080/17425247.2018.1503249
   PubMed Web of Science ®Google Scholar
• Mao Y, Feng S, Li S, et al. Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs. Biomaterials. 2019;188:173–186. doi:10.1016/j.biomaterials.2018.10.012
   PubMed Web of Science ®Google Scholar
• Yáñez JA, Wang SW, Knemeyer IW, Wirth MA, Alton KB. Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev. 2011;63(10–11):923–942. doi:10.1016/j.addr.2011.05.019
   PubMed Web of Science ®Google Scholar
• Elz AS, Trevaskis NL, Porter CJH, Bowen JM, Prestidge CA. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport. J Control Release. 2022;341:676–701. doi:10.1016/j.jconrel.2021.12.003
   PubMed Web of Science ®Google Scholar
• Lee JB, Zgair A, Malec J, et al. Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system. J Control Release. 2018;286:10–19. doi:10.1016/j.jconrel.2018.07.022
   PubMed Web of Science ®Google Scholar
• Qin C, Chu Y, Feng W, et al. Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach. J Control Release. 2021;329:1077–1089. doi:10.1016/j.jconrel.2020.10.036
   PubMed Web of Science ®Google Scholar
• Mu H, Høy CE. The digestion of dietary triacylglycerols. Prog Lipid Res. 2004;43(2):105–133. doi:10.1016/s0163-7827(03)00050-x
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Kaminskas LM, Porter CJ. From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Discov. 2015;14(11):781–803. doi:10.1038/nrd4608
   PubMed Web of Science ®Google Scholar
• Huang L, Yang J, Wang T, Gao J, Xu D. Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery. J Nanobiotechnology. 2022;20(1):49. doi:10.1186/s12951-022-01257-4
   PubMed Web of Science ®Google Scholar
• Hokkanen K, Tirronen A, Ylä-Herttuala S. Intestinal lymphatic vessels and their role in chylomicron absorption and lipid homeostasis. Curr Opin Lipidol. 2019;30(5):370–376. doi:10.1097/mol.0000000000000626
   PubMed Web of Science ®Google Scholar
• Julve J, Martín-Campos JM, Escolà-Gil JC, Blanco-Vaca F. Chylomicrons: advances in biology, pathology, laboratory testing, and therapeutics. Clin Chim Acta. 2016;455:134–148. doi:10.1016/j.cca.2016.02.004
   PubMed Web of Science ®Google Scholar
• Ahammed V, Narayan R, Paul J, et al. Development and in vivo evaluation of functionalized ritonavir proliposomes for lymphatic targeting. Life Sci. 2017;183:11–20. doi:10.1016/j.lfs.2017.06.022
   PubMed Web of Science ®Google Scholar
• Xia F, Chen Z, Zhu Q, et al. Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route. Acta pharmaceutica Sinica B. 2021;11(4):1010–1020. doi:10.1016/j.apsb.2021.03.006
   PubMed Web of Science ®Google Scholar
• Ye J, Gao Y, Ji M, et al. Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity. J Immunother Cancer. 2021;9(7). doi:10.1136/jitc-2021-002753
   Web of Science ®Google Scholar
• Liao H, Gao Y, Lian C, et al. Oral absorption and lymphatic transport of baicalein following drug-phospholipid complex incorporation in self-microemulsifying drug delivery systems. Int J Nanomed. 2019;14:7291–7306. doi:10.2147/ijn.S214883
   PubMed Web of Science ®Google Scholar
• Cho HJ, Park JW, Yoon IS, Kim DD. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomed. 2014;9:495–504. doi:10.2147/ijn.S56648
   PubMed Web of Science ®Google Scholar
• Mirchandani Y, Patravale VB. Solid lipid nanoparticles for hydrophilic drugs. J Control Release. 2021;335:457–464. doi:10.1016/j.jconrel.2021.05.032
   PubMed Web of Science ®Google Scholar
• Khan S, Sharma A, Jain V. An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv Pharm Bull. 2023;13(3):446–460. doi:10.34172/apb.2023.056
   PubMed Web of Science ®Google Scholar
• Yao M, Li Z, Julian mcclements D, Tang Z, Xiao H. Design of nanoemulsion-based delivery systems to enhance intestinal lymphatic transport of lipophilic food bioactives: influence of oil type. Food Chem. 2020;317:126229. doi:10.1016/j.foodchem.2020.126229
   PubMed Web of Science ®Google Scholar
• Singh Y, Meher JG, Raval K, et al. Nanoemulsion: concepts, development and applications in drug delivery. J Control Release. 2017;252:28–49. doi:10.1016/j.jconrel.2017.03.008
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang C, Han N, et al. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism. Drug Deliv. 2021;28(1):1664–1672. doi:10.1080/10717544.2021.1960928
   PubMed Web of Science ®Google Scholar
• Miao YB, Xu T, Gong Y, et al. Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy. J Nanobiotechnology. 2023;21(1):263. doi:10.1186/s12951-023-01991-3
   PubMed Web of Science ®Google Scholar
• Lan HR, Zhang YN, Han YJ, et al. Multifunctional nanocarriers for targeted drug delivery and diagnostic applications of lymph nodes metastasis: a review of recent trends and future perspectives. J Nanobiotechnology. 2023;21(1):247. doi:10.1186/s12951-023-01990-4
   PubMed Web of Science ®Google Scholar
• Xiao C, Stahel P, Carreiro AL, Buhman KK, Lewis GF. Recent Advances in Triacylglycerol Mobilization by the Gut. Trends Endocrinol Metab. 2018;29(3):151–163. doi:10.1016/j.tem.2017.12.001
   PubMed Web of Science ®Google Scholar
• Ren G, Duan D, Wang G, et al. Construction of reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled nanoparticles with antitumor activity. Colloids Surf B Biointerfaces. 2022;217:112614. doi:10.1016/j.colsurfb.2022.112614
   PubMed Web of Science ®Google Scholar
• Cai X, Miao J, Sun R, et al. Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer. Pharmacol Res. 2021;170:105701. doi:10.1016/j.phrs.2021.105701
   PubMed Web of Science ®Google Scholar
• Guo XH, Ding F, Lian X, et al. The efficiency and mechanism of a new absorption enhancer, malic acid, for enhancing the oral bioavailability of docetaxel. Pharm Dev Technol. 2021;26(5):592–598. doi:10.1080/10837450.2021.1904259
   PubMed Web of Science ®Google Scholar
• Kang XJ, Wang HY, Peng HG, et al. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy. Acta Pharmacol Sin. 2017;38(6):885–896. doi:10.1038/aps.2017.10
   PubMed Web of Science ®Google Scholar
• Stankovich S, Piner RD, Nguyen SBT, Ruoff RSJEL. Synthesis and exfoliation of isocyanate-treated graphene oxide nanoplatelets. Carbon. 2006;15. doi:10.1016/J.carbon.2006.06.004
   Web of Science ®Google Scholar
• Thottacherry JJ, Sathe M, Prabhakara C, Mayor S. Spoiled for choice: diverse endocytic pathways function at the cell surface. Annu Rev Cell Dev Biol. 2019;35:55–84. doi:10.1146/annurev-cellbio-100617-062710
   PubMed Web of Science ®Google Scholar
• Un K, Sakai-Kato K, Oshima Y, Kawanishi T, Okuda H. Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomes. Biomaterials. 2012;33(32):8131–8141. doi:10.1016/j.biomaterials.2012.07.030
   PubMed Web of Science ®Google Scholar
• Zou Y, Gao W, Jin H, et al. Cellular uptake and transport mechanism of 6-mercaptopurine nanomedicines for enhanced oral bioavailability. Int J Nanomed. 2023;18:79–94. doi:10.2147/ijn.S394819
   PubMed Web of Science ®Google Scholar
• Li X, Jafari SM, Zhou F, et al. The intracellular fate and transport mechanism of shape, size and rigidity varied nanocarriers for understanding their oral delivery efficiency. Biomaterials. 2023;294:121995. doi:10.1016/j.biomaterials.2023.121995
   PubMed Web of Science ®Google Scholar
• Cefalù AB, D’Erasmo L, Iannuzzo G, et al. Efficacy and safety of lomitapide in familial chylomicronaemia syndrome. Atherosclerosis. 2022;359:13–19. doi:10.1016/j.atherosclerosis.2022.08.017
   PubMed Web of Science ®Google Scholar
• Bao X, Qian K, Xu M, et al. Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery. J Nanobiotechnology. 2023;21(1):16. doi:10.1186/s12951-022-01743-9
   PubMed Web of Science ®Google Scholar
• Liu W, Han Y, Xin X, et al. Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs. J Nanobiotechnology. 2022;20(1):281. doi:10.1186/s12951-022-01460-3
   PubMed Web of Science ®Google Scholar
• Bernier-Latmani J, Petrova TV. Intestinal lymphatic vasculature: structure, mechanisms and functions. Nat Rev Gastroenterol Hepatol. 2017;14(9):510–526. doi:10.1038/nrgastro.2017.79
   PubMed Web of Science ®Google Scholar
• Choe K, Jang JY, Park I, et al. Intravital imaging of intestinal lacteals unveils lipid drainage through contractility. J Clin Invest. 2015;125(11):4042–4052. doi:10.1172/jci76509
   PubMed Web of Science ®Google Scholar
• Johnson OW, Chick JF, Chauhan NR, et al. The thoracic duct: clinical importance, anatomic variation, imaging, and embolization. Eur Radiol. 2016;26(8):2482–2493. doi:10.1007/s00330-015-4112-6
   PubMed Web of Science ®Google Scholar
• Al Nebaihi HM, Davies NM, Brocks DR. Pharmacokinetics of cycloheximide in rats and evaluation of its effect as a blocker of intestinal lymph formation. Eur J Pharm Biopharm. 2023;193:89–95. doi:10.1016/j.ejpb.2023.10.016
   PubMed Web of Science ®Google Scholar
• Zhou A, Lu T, Wang L, et al. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats. Pharm Dev Technol. 2014;19(6):743–747. doi:10.3109/10837450.2013.829093
   PubMed Web of Science ®Google Scholar
• Zhou X, Ling K, Liu M, et al. Targeted delivery of cisplatin-derived nanoprecursors via a biomimetic yeast microcapsule for tumor therapy by the oral route. Theranostics. 2019;9(22):6568–6586. doi:10.7150/thno.35353
   PubMed Web of Science ®Google Scholar
• Yamazoe E, Fang JY, Tahara K. Oral mucus-penetrating PEGylated liposomes to improve drug absorption: differences in the interaction mechanisms of a mucoadhesive liposome. Int J Pharm. 2021;593:120148. doi:10.1016/j.ijpharm.2020.120148
   PubMed Web of Science ®Google Scholar
• Dhiman N, Sarvaiya J, Mohindroo P. A drift on liposomes to proliposomes: recent advances and promising approaches. J Liposome Res. 2022;32(4):317–331. doi:10.1080/08982104.2021.2019762
   PubMed Web of Science ®Google Scholar
• Righeschi C, Coronnello M, Mastrantoni A, et al. Strategy to provide a useful solution to effective delivery of dihydroartemisinin: development, characterization and in vitro studies of liposomal formulations. Colloids Surf B Biointerfaces. 2014;116:121–127. doi:10.1016/j.colsurfb.2013.12.019
   PubMed Web of Science ®Google Scholar
• Malik JA, Ansari JA, Ahmed S, et al. Nano-drug delivery system: a promising approach against breast cancer. Ther Deliv. 2023;14(5):357–381. doi:10.4155/tde-2023-0020
   PubMed Web of Science ®Google Scholar
• Nguyen TX, Huang L, Gauthier M, Yang G, Wang Q. Recent advances in liposome surface modification for oral drug delivery. Nanomedicine. 2016;11(9):1169–1185. doi:10.2217/nnm.16.9
   PubMed Web of Science ®Google Scholar
• He H, Xie Y, Lv Y, et al. Bioimaging of intact polycaprolactone nanoparticles using aggregation-caused quenching probes: size-dependent translocation via oral delivery. Adv Healthc Mater. 2018;7(22):e1800711. doi:10.1002/adhm.201800711
   PubMed Web of Science ®Google Scholar
• McCright J, Skeen C, Yarmovsky J, Maisel K. Nanoparticles with dense poly(ethylene glycol) coatings with near neutral charge are maximally transported across lymphatics and to the lymph nodes. Acta Biomater. 2022;145:146–158. doi:10.1016/j.actbio.2022.03.054
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang X, Han S, et al. Yeast microcapsule-mediated targeted delivery of diverse nanoparticles for imaging and therapy via the oral route. Nano Lett. 2017;17(2):1056–1064. doi:10.1021/acs.nanolett.6b04523
   PubMed Web of Science ®Google Scholar